Why is Parmax Pharma falling/rising?

As of 14-Jul, Parmax Pharma Ltd's stock price is currently at Rs 39.06, reflecting a decrease of Rs 2.94, or 7.0%. Today's price summary indicates that the stock opened significantly lower, down 13.1%, and has experienced high volatility with an intraday range of Rs 4.86. The stock has underperformed its sector by 7.9% today, and its delivery volume has decreased by 2.61% compared to the 5-day average, suggesting a decline in investor participation. Despite reporting positive results for the last three consecutive quarters and a substantial growth in net sales, the company faces challenges such as a negative book value and weak long-term fundamentals, which contribute to its current price decline.
In the broader market context, Parmax Pharma's short-term performance shows a 1.45% increase over the past week, contrasting with the Sensex, which has decreased by 1.42%. However, the stock's year-to-date performance is notably poor, with a decline of 11.73%, while the Sensex has gained 5.27%. This disparity highlights the stock's struggles relative to the overall market. The company's weak ability to service its debt and negative operating profits further exacerbate its risk profile, making it less attractive to investors despite recent sales growth.